(2-oxo-1,3-benzoxazol-3(2H)-yl)acetonitrile, 95.0%, 1g

2-Hydroxy-4,5-dimethoxybenzoic acid, 95.0%, 25g

3-(3-Fluoro-4-methylphenyl)piperidine, 97%, 250mg

(2-Phenoxyphenyl)methanol, 95.0%, 5g

4,4,5,5-Tetramethyl-1,3,2-dioxaphospholane 2-Oxide, 95.0%, 200mg

Br-Mmc (=4-Bromomethyl-7-methoxycoumarin) [for HPLC Labeling]>98.0%(T)5g

9-Phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole, 97%, 5g

4-Chloro-2-methyl-pyrimidine, 95.0%, 100g

Chambre de séparation CCM, 1 pièce(s)

2-Amino-5-bromopyrazine>98.0%(GC)(T)5g

2,3,3,3-Tetrafluoro-2-(perfluoropropoxy)propanoic acid, 97%, 25g

[3-(2-furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid, 95.0%, 1g

Ethyl {2-[(Chloroacetyl)amino]-1,3-thiazol-4-yl}acetate, 97.0%, 10g